Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | MedicalExpress (São Paulo. Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2358-04292016000300005 |
Resumo: | OBJECTIVE: This study aimed to assess the adherence to antiretroviral treatment of HIV-infected patients at the Centro de Referência Viva Vida in Patos de Minas, Minas Gerais, Brazil. METHODS: As a descriptive and quantitative retrospective cross-sectional study, we enlisted HIV-infected patients, over 18 years old, users of highly active antiretroviral therapy (HAART) from June 2011 to July 2012. Data on withdrawal of medication and viral load were collected from the drug logistics management information system and from the medical records, respectively. Sociodemographic and data regarding HAART use were collected manually, using appropriate forms. The CEAT-HIV questionnaire was filled out by140 patients who were using HAART. For data analysis, we used ANOVA and Kruskal-Wallis Rank Sum tests, complemented with Dunn's test, when necessary. P < 0.05 was adopted as the limit for significance. RESULTS: The age group 18-30 years presented lower adherence compared with the group aged over 60 years (p = 0.047). Regarding the HAART usage time, there was no difference between groups (p = 0.515). For the number of pills taken per day, there was greater adherence for patients taking up to 4 pills compared to those taking 5-10 pills daily (p = 0.037). Concerning adherence measured by the CEAT-HIV questionnaire, there was strict/rigorous adherence in 57.8% of patients, with 21.4% of the patients classified as having adequate adherence, according to the data on dispensation of medicines. CONCLUSION: Patients participating in HAART and taking up to 4 pills had good adherence to treatment. |
id |
METC-1_19be9b206260343ece2554323f2f2e36 |
---|---|
oai_identifier_str |
oai:scielo:S2358-04292016000300005 |
network_acronym_str |
METC-1 |
network_name_str |
MedicalExpress (São Paulo. Online) |
repository_id_str |
|
spelling |
Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, BrazilAdherenceComplianceHAARTHIV/AIDS OBJECTIVE: This study aimed to assess the adherence to antiretroviral treatment of HIV-infected patients at the Centro de Referência Viva Vida in Patos de Minas, Minas Gerais, Brazil. METHODS: As a descriptive and quantitative retrospective cross-sectional study, we enlisted HIV-infected patients, over 18 years old, users of highly active antiretroviral therapy (HAART) from June 2011 to July 2012. Data on withdrawal of medication and viral load were collected from the drug logistics management information system and from the medical records, respectively. Sociodemographic and data regarding HAART use were collected manually, using appropriate forms. The CEAT-HIV questionnaire was filled out by140 patients who were using HAART. For data analysis, we used ANOVA and Kruskal-Wallis Rank Sum tests, complemented with Dunn's test, when necessary. P < 0.05 was adopted as the limit for significance. RESULTS: The age group 18-30 years presented lower adherence compared with the group aged over 60 years (p = 0.047). Regarding the HAART usage time, there was no difference between groups (p = 0.515). For the number of pills taken per day, there was greater adherence for patients taking up to 4 pills compared to those taking 5-10 pills daily (p = 0.037). Concerning adherence measured by the CEAT-HIV questionnaire, there was strict/rigorous adherence in 57.8% of patients, with 21.4% of the patients classified as having adequate adherence, according to the data on dispensation of medicines. CONCLUSION: Patients participating in HAART and taking up to 4 pills had good adherence to treatment.Mavera Edições Técnicas e Científicas Ltda2016-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2358-04292016000300005MedicalExpress v.3 n.3 2016reponame:MedicalExpress (São Paulo. Online)instname:Mavera Edições Científicas e Técnicas Ltda-MEinstacron:METC10.5935/MedicalExpress.2016.03.05info:eu-repo/semantics/openAccessSouza,Gabriela de OliveiraTibúrcio,Aline Andréia Caixeta MagalhãesKoike,Márcia Kiyomieng2016-06-14T00:00:00Zoai:scielo:S2358-04292016000300005Revistahttp://www.medicalexpress.net.brhttps://old.scielo.br/oai/scielo-oai.php||medicalexpress@me.net.br2358-04292318-8111opendoar:2016-06-14T00:00MedicalExpress (São Paulo. Online) - Mavera Edições Científicas e Técnicas Ltda-MEfalse |
dc.title.none.fl_str_mv |
Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil |
title |
Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil |
spellingShingle |
Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil Souza,Gabriela de Oliveira Adherence Compliance HAART HIV/AIDS |
title_short |
Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil |
title_full |
Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil |
title_fullStr |
Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil |
title_full_unstemmed |
Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil |
title_sort |
Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil |
author |
Souza,Gabriela de Oliveira |
author_facet |
Souza,Gabriela de Oliveira Tibúrcio,Aline Andréia Caixeta Magalhães Koike,Márcia Kiyomi |
author_role |
author |
author2 |
Tibúrcio,Aline Andréia Caixeta Magalhães Koike,Márcia Kiyomi |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Souza,Gabriela de Oliveira Tibúrcio,Aline Andréia Caixeta Magalhães Koike,Márcia Kiyomi |
dc.subject.por.fl_str_mv |
Adherence Compliance HAART HIV/AIDS |
topic |
Adherence Compliance HAART HIV/AIDS |
description |
OBJECTIVE: This study aimed to assess the adherence to antiretroviral treatment of HIV-infected patients at the Centro de Referência Viva Vida in Patos de Minas, Minas Gerais, Brazil. METHODS: As a descriptive and quantitative retrospective cross-sectional study, we enlisted HIV-infected patients, over 18 years old, users of highly active antiretroviral therapy (HAART) from June 2011 to July 2012. Data on withdrawal of medication and viral load were collected from the drug logistics management information system and from the medical records, respectively. Sociodemographic and data regarding HAART use were collected manually, using appropriate forms. The CEAT-HIV questionnaire was filled out by140 patients who were using HAART. For data analysis, we used ANOVA and Kruskal-Wallis Rank Sum tests, complemented with Dunn's test, when necessary. P < 0.05 was adopted as the limit for significance. RESULTS: The age group 18-30 years presented lower adherence compared with the group aged over 60 years (p = 0.047). Regarding the HAART usage time, there was no difference between groups (p = 0.515). For the number of pills taken per day, there was greater adherence for patients taking up to 4 pills compared to those taking 5-10 pills daily (p = 0.037). Concerning adherence measured by the CEAT-HIV questionnaire, there was strict/rigorous adherence in 57.8% of patients, with 21.4% of the patients classified as having adequate adherence, according to the data on dispensation of medicines. CONCLUSION: Patients participating in HAART and taking up to 4 pills had good adherence to treatment. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-06-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2358-04292016000300005 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2358-04292016000300005 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.5935/MedicalExpress.2016.03.05 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Mavera Edições Técnicas e Científicas Ltda |
publisher.none.fl_str_mv |
Mavera Edições Técnicas e Científicas Ltda |
dc.source.none.fl_str_mv |
MedicalExpress v.3 n.3 2016 reponame:MedicalExpress (São Paulo. Online) instname:Mavera Edições Científicas e Técnicas Ltda-ME instacron:METC |
instname_str |
Mavera Edições Científicas e Técnicas Ltda-ME |
instacron_str |
METC |
institution |
METC |
reponame_str |
MedicalExpress (São Paulo. Online) |
collection |
MedicalExpress (São Paulo. Online) |
repository.name.fl_str_mv |
MedicalExpress (São Paulo. Online) - Mavera Edições Científicas e Técnicas Ltda-ME |
repository.mail.fl_str_mv |
||medicalexpress@me.net.br |
_version_ |
1754734597046796288 |